Ammonul FDA Approval History
FDA Approved: Yes (First approved February 17, 2005)
Brand name: Ammonul
Generic name: sodium benzoate and sodium phenylacetate
Dosage form: Injection
Company: Medicis
Treatment for: Hyperammonemia
Ammonul (sodium benzoate and sodium phenylacetate) is indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
Development timeline for Ammonul
| Date | Article |
|---|---|
| Feb 17, 2005 | Approval Ammonul Medicis - Treatment for Urea Cycle Disorder |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
